Blueprint Medicines Statistics
Total Valuation
HKG:1520 has a market cap or net worth of HKD 1.19 billion. The enterprise value is 1.15 billion.
Market Cap | 1.19B |
Enterprise Value | 1.15B |
Important Dates
The next estimated earnings date is Friday, August 29, 2025.
Earnings Date | Aug 29, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
HKG:1520 has 793.20 million shares outstanding. The number of shares has increased by 15.61% in one year.
Current Share Class | 793.20M |
Shares Outstanding | 793.20M |
Shares Change (YoY) | +15.61% |
Shares Change (QoQ) | +11.16% |
Owned by Insiders (%) | 15.57% |
Owned by Institutions (%) | 8.62% |
Float | 639.46M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 9.18 |
PB Ratio | 9.15 |
P/TBV Ratio | 10.71 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -14.99 |
EV / Sales | 8.87 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | -14.53 |
Financial Position
The company has a current ratio of 2.79, with a Debt / Equity ratio of 0.20.
Current Ratio | 2.79 |
Quick Ratio | 2.12 |
Debt / Equity | 0.20 |
Debt / EBITDA | n/a |
Debt / FCF | -0.34 |
Interest Coverage | -8.44 |
Financial Efficiency
Return on equity (ROE) is -56.08% and return on invested capital (ROIC) is -20.69%.
Return on Equity (ROE) | -56.08% |
Return on Assets (ROA) | -17.10% |
Return on Invested Capital (ROIC) | -20.69% |
Return on Capital Employed (ROCE) | -40.53% |
Revenue Per Employee | 1.73M |
Profits Per Employee | -1.02M |
Employee Count | 75 |
Asset Turnover | 0.63 |
Inventory Turnover | 11.20 |
Taxes
In the past 12 months, HKG:1520 has paid 1.72 million in taxes.
Income Tax | 1.72M |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +3,066.67% in the last 52 weeks. The beta is 0.08, so HKG:1520's price volatility has been lower than the market average.
Beta (5Y) | 0.08 |
52-Week Price Change | +3,066.67% |
50-Day Moving Average | 0.80 |
200-Day Moving Average | 0.57 |
Relative Strength Index (RSI) | 74.85 |
Average Volume (20 Days) | 20,313,728 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, HKG:1520 had revenue of HKD 129.60 million and -76.63 million in losses. Loss per share was -0.13.
Revenue | 129.60M |
Gross Profit | 9.03M |
Operating Income | -56.00M |
Pretax Income | -76.45M |
Net Income | -76.63M |
EBITDA | -55.20M |
EBIT | -56.00M |
Loss Per Share | -0.13 |
Balance Sheet
The company has 66.51 million in cash and 26.60 million in debt, giving a net cash position of 39.91 million or 0.05 per share.
Cash & Cash Equivalents | 66.51M |
Total Debt | 26.60M |
Net Cash | 39.91M |
Net Cash Per Share | 0.05 |
Equity (Book Value) | 130.02M |
Book Value Per Share | 0.20 |
Working Capital | 101.76M |
Cash Flow
In the last 12 months, operating cash flow was -77.71 million and capital expenditures -1.39 million, giving a free cash flow of -79.10 million.
Operating Cash Flow | -77.71M |
Capital Expenditures | -1.39M |
Free Cash Flow | -79.10M |
FCF Per Share | -0.10 |
Margins
Gross margin is 6.97%, with operating and profit margins of -43.21% and -59.13%.
Gross Margin | 6.97% |
Operating Margin | -43.21% |
Pretax Margin | -58.99% |
Profit Margin | -59.13% |
EBITDA Margin | -42.60% |
EBIT Margin | -43.21% |
FCF Margin | n/a |
Dividends & Yields
HKG:1520 does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -15.61% |
Shareholder Yield | n/a |
Earnings Yield | -6.44% |
FCF Yield | -6.65% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
The last stock split was on November 20, 2024. It was a reverse split with a ratio of 0.25.
Last Split Date | Nov 20, 2024 |
Split Type | Reverse |
Split Ratio | 0.25 |
Scores
HKG:1520 has an Altman Z-Score of -0.43 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -0.43 |
Piotroski F-Score | 2 |